Drug Pricing: An Intelligent Conversation Worth 60 Minutes

Kaiser Family Foundation has posted an excellent web panel discussion on drug pricing. Representatives from Pfizer, a large international pharmaceutical company; Express Scripts, and Aetna, a major health insurance carrier, talk with Larry Levitt, a Kaiser senior vice president.

There are no slides, no canned presentations and little advocacy of any certain position. Instead, Mr. Levitt facilitates an engaging and intelligent conversation that examines all sides of the issue and explores the interplay of price, profit and innovation.

This one-hour conversation is a must-listen for policymakers. It is also available as a podcast

Tags: